Skip to main content

Specialties
Resources for Physicians
Resources for Your Patients

Search Videos and More

search

Channel Categories

Cancer (1)
Cardiology, Heart & Vascular Surgery (3)
Diabetes & Endocrinology (17)
Gastroenterology (3)
Geriatric Medicine (1)
Neurology (1)
Neurosurgery (1)
Obstetrics & Gynecology (1)
Ophthalmology (1)
Orthopaedics (1)
Other Programs (1)
Otolaryngology (1)
Physical Medicine and Rehabilitation (1)
Psychiatry (1)
Pulmonology (1)
Rheumatology (1)
Urology (1)

Types

News (16)
Video Asset (1)

Conditions

[E08.00] Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) (1)
[E08.32] Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy (1)
[E10.9] Type 1 diabetes mellitus without complications (1)
[E11.0] Type 2 diabetes mellitus with hyperosmolarity (1)
[Z79.0] Long term (current) use of anticoagulants and antithrombotics/antiplatelets (1)

Procedures

[81506] Endocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, hba1c, insulin, hs-crp, adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithm reporting a risk score (1)
[82947] Blood glucose (sugar) level (2)
[95249] Continuous monitoring of glucose in tissue fluid using sensor under skin (1)
[95250] Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours (1)

Showing 13 - 17 of 17 results

Previous| 1 | 2 |Next

Common Weight-Loss Drug Successfully Targets Fat that Can Endanger Heart Health

Common Weight-Loss Drug Successfully Targets Fat that Can Endanger Heart Health

A common weight-loss drug successfully targets fat that can endanger heart health.

Giving Brown Fat a Boost to Fight Type 2 Diabetes

Giving Brown Fat a Boost to Fight Type 2 Diabetes

Increasing a protein concentrated in brown fat appears to lower blood sugar, promote insulin sensitivity, and protect against fatty liver disease by remodeling white fat to a healthier state, a new study led by UT Southwestern scientists suggests.

Once-a-week Insulin Treatment Could Be Game-changing for Patients with Diabetes

Once-a-week Insulin Treatment Could Be Game-changing for Patients with Diabetes

Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international clinical trials published online today in Diabetes Care.

Drug Found Effective for Weight Loss in Patients with Obesity and Diabetes, International Study Shows

Drug Found Effective for Weight Loss in Patients with Obesity and Diabetes, International Study Shows

A drug approved for diabetes has now been shown to also help patients with diabetes lose on average 10 percent of their body weight, UT Southwestern reports in a landmark international study.

Swapping Alpha Cells for Beta Cells to Treat Diabetes

Swapping Alpha Cells for Beta Cells to Treat Diabetes

Antibodies that convert glucagon-producing cells into insulin-producing ones cure mouse models of the disease

Showing 13 - 17 of 17 results

Previous| 1 | 2 |Next

Powered by BROADCASTMED

About UT Southwestern Medical Center

UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty members have received six Nobel Prizes and include 25 members of the National Academy of Sciences, 24 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 3,200 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in more than 80 specialties to more than 120,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 5 million outpatient visits a year.